M. Beaulieu

发表

L. Soucek, M. Beaulieu, 2019, Molecular & cellular oncology.

J. Whitfield, L. Soucek, M. Beaulieu, 2017, Front. Cell Dev. Biol..

L. Soucek, D. Massó-Vallés, M. Beaulieu, 2020, Expert opinion on therapeutic targets.

J. Arribas, L. Larsson, V. Serra, 2022, Cancer research communications.

J. Stankova, M. Rola-Pleszczynski, C. Le Gouill, 2004, Journal of Biological Chemistry.

G. Evan, L. Brown-Swigart, D. Virshup, 2021, Life Science Alliance.

M. Guenther, P. Rahl, J. Whitfield, 2019, Science Translational Medicine.

P. Lavigne, M. Bédard, Loïka Maltais, 2012, Journal of Biomolecular NMR.

P. Lavigne, M. Bédard, Marie-Eve Beaulieu, 2012, Journal of biomolecular NMR.

R. Leduc, Jean-Michel Longpré, A. Désilets, 2006, FEBS letters.

T. Jauset, Marie-Eve Beaulieu, M. Beaulieu, 2019, Current opinion in pharmacology.

J. Yokota, B. Haendler, J. Whitfield, 2018, Oncotarget.

Christophe D. Proulx, R. Leduc, E. Escher, 2007, The Biochemical journal.

L. Soucek, S. Martínez-Martín, M. Beaulieu, 2023, Cancer drug resistance.

Pierre Lavigne, R. Leduc, E. Escher, 2012, The Journal of Biological Chemistry.

J. Stankova, M. Rola-Pleszczynski, C. Le Gouill, 2004, Journal of Biological Chemistry.

L. Soucek, M. Beaulieu, Hugo Thabussot, 2024, GEN Biotechnology.

J. Whitfield, L. Soucek, T. Jauset, 2017 .